Autor: |
Kikwai GK; Diagnostic and Laboratory System Programme, Center for Global Health Research, Kenya Medical Research Institute, Nairobi, Kenya., Juma B; Division of Global Health Protection, Centers for Disease Control and Prevention-Kenya, Nairobi, Kenya., Nindo F; Bioinformatics and Informatics Platform, Institute of Research on Cancer and Aging, Medical School, University of Cote d'Azur, Nice, France.; Division of Medical Microbiology, Department of Pathology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa., Ochieng C; Diagnostic and Laboratory System Programme, Center for Global Health Research, Kenya Medical Research Institute, Nairobi, Kenya., Wamola N; Diagnostic and Laboratory System Programme, Center for Global Health Research, Kenya Medical Research Institute, Nairobi, Kenya., Mbogo K; Biochemistry Department, College of Health Sciences, Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya., Call DR; Paul G. Allen School for Global Health, Washington State University, Pullman, Washington, USA., Hunsperger E; Division of Global Health Protection, Centers for Disease Control and Prevention-Kenya, Nairobi, Kenya. |
Abstrakt: |
An Escherichia coli strain (sequence type 636) was isolated from an adult residing in an urban informal settlement in Nairobi, Kenya, and was sequenced using the Illumina MiSeq platform. The draft genome was 5,075,726 bp, with a Col(BS512) plasmid plus aph(6)-Id , bla TEM-1B , and dfrA7 genes, which encode kanamycin, ampicillin, and trimethoprim resistance proteins, respectively. |